These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1532096)

  • 21. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experiences with the use of sulprostone (Nalador) for the termination of pregnancy in the 1st trimester in primigravidae].
    Rudolf K; Lober R; Rüting M; Thomas K; Drewelow B; Nikschick S; During R; Knispel J
    Zentralbl Gynakol; 1987; 109(23):1409-15. PubMed ID: 3442150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
    Fiala C; Gemzel-Danielsson K
    Contraception; 2006 Jul; 74(1):66-86. PubMed ID: 16781264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sulprostone in the treatment of uterine inertia. Report of 60 cases].
    Mathlouthi N; Khemiri B; Chennoufi MB; Elhusseini A; Ellouze H; Bouchnak M; Hendaoui MS; Maghrebi H; Sfar E; Chelli H
    Tunis Med; 2004 Oct; 82(10):958-63. PubMed ID: 15686193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
    Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Termination of pregnancy with a mifepristone-sulprostone combination].
    Maria B; Stampf F
    Presse Med; 1987 Dec; 16(42):2128-9. PubMed ID: 2963290
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical abortion pills have the potential to change everything about abortion.
    Berer M; Hoggart L
    Contraception; 2018 Feb; 97(2):79-81. PubMed ID: 29242083
    [No Abstract]   [Full Text] [Related]  

  • 28. Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
    Gómez O; Borrás A; Rabanal A; Palacio M; Carceller A; Coll O; Gratacós E
    Contraception; 2010 Feb; 81(2):97-101. PubMed ID: 20103444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of sulprostone for cervical dilation in nulliparas during 1st trimester abortions].
    Giannone R; Poli M; Bernardi F; Ferrari E
    Minerva Ginecol; 1988 Sep; 40(9):553-5. PubMed ID: 3222011
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience in using the preparation nalador for terminating pregnancy in the 2d trimester].
    Chernaia VV; Zak IR; Gridchik AL
    Akush Ginekol (Mosk); 1986 Aug; (8):50-2. PubMed ID: 3766899
    [No Abstract]   [Full Text] [Related]  

  • 31. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial.
    Shaw KA; Shaw JG; Hugin M; Velasquez G; Hopkins FW; Blumenthal PD
    Contraception; 2015 Apr; 91(4):313-9. PubMed ID: 25499589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Induced termination of second and third trimester pregnancy in women with scarred uterus].
    Zou LY; Fan L
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contraceptive activity of RU486 and oral active prostaglandin combination].
    Aubeny E; Baulieu EE
    C R Acad Sci III; 1991; 312(11):539-45. PubMed ID: 1906363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An experimental study of sulprostone as an agent in preparation for abortion].
    Korkhov VV; Mats MN; Boĭkova VV; Zaĭtseva MA
    Eksp Klin Farmakol; 1993; 56(4):37-9. PubMed ID: 8220013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiprogesterone, prostaglandin analogues and the early interruption of pregnancy].
    Maria B
    Rev Fr Gynecol Obstet; 1990 Apr; 85(4):238-42. PubMed ID: 2195626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trends since 1989, in France, of induced abortions by mifepristone (RU486) combined with a prostaglandin analogue].
    Aubeny E
    Contracept Fertil Sex; 1997 Oct; 25(10):777-81. PubMed ID: 9424216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of sulprostone in abortion induced during the first pregnancy trimester in women with previous cesarean section].
    Giannone R; Bernardi F; Ferrari E; Poli M
    Minerva Ginecol; 1990 Sep; 42(9):357-8. PubMed ID: 2284043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.